Causes of Stroke Explained

A stroke has one of two root mechanisms — a blocked artery or a ruptured one — but several distinct underlying causes feed into each:

• Ischemic stroke (≈85% of cases): A blood clot or atherosclerotic plaque blocks an artery supplying the brain, cutting off oxygen to the tissue it serves.
• Hemorrhagic stroke: A blood vessel in the brain ruptures, causing bleeding, pressure buildup, and direct tissue damage — this includes both intracerebral and subarachnoid hemorrhage.
• Cardioembolic causes: Blood clots forming in the heart, often due to atrial fibrillation, that travel to and lodge in cerebral arteries.
• Small vessel disease: Chronic damage to tiny penetrating arteries deep in the brain, producing lacunar infarcts that often affect movement or cognition subtly rather than dramatically.
• Modifiable risk factors: Hypertension, diabetes, high cholesterol, smoking, atrial fibrillation, and obesity are the risk factors most within a patient’s control to manage.

Why the ischemic-vs-hemorrhagic distinction matters here

This distinction is not just diagnostic detail — it changes candidacy for regenerative approaches. Most of the clinical trial evidence reviewed under Scientific References was conducted specifically in ischemic stroke patients; hemorrhagic stroke has a smaller and different evidence base. If your diagnosis is hemorrhagic, this should be discussed explicitly with your specialist rather than assumed to carry the same evidence as the ischemic studies cited on this page.

Related reading: How Stem Cell Therapy Works for the general mechanism, or see Cardiovascular Disease if atrial fibrillation or cardiac causes are part of your history.

Symptoms of Stroke

Stroke symptoms appear suddenly, and recognizing them within minutes directly affects how much brain tissue can be saved. This is a genuine medical emergency, not a “watch and wait” situation.

• Sudden weakness or numbness — typically on one side of the face, arm, or leg.
• Sudden confusion or trouble speaking — including slurred speech or difficulty understanding others.
• Sudden vision trouble — in one or both eyes.
• Sudden loss of balance or coordination — difficulty walking, dizziness, or unsteadiness.
• Sudden severe headache — with no known cause, particularly associated with hemorrhagic stroke.

Act FAST

Face drooping · Arm weakness · Speech difficulty · Time to call emergency services.

If you or someone near you shows any of these signs, call emergency services immediately — do not wait to see if symptoms pass, and do not attempt to drive to a hospital yourself. Every minute of delay affects how much brain tissue survives.

Note: This page addresses regenerative treatment options for stroke survivors managing ongoing deficits after acute care — it is not a substitute for emergency treatment. If you’re reading this during an active stroke event, stop and call emergency services now.

Diagnosis of Stroke

Diagnosis in the acute phase is designed to answer one question fast: is this a bleed or a blockage, and how much brain tissue is at risk? Later, once a patient is stable, diagnosis shifts to characterizing residual deficits — which is what determines candidacy for the regenerative approaches discussed on this page.

For patients considering regenerative therapy months or years after their stroke, we also require current imaging (not just imaging from the time of the original event) to confirm lesion status before proposing any protocol. Upload existing reports for a free case review rather than repeating imaging unnecessarily if you have recent scans available.

Stem Cell Treatment for Stroke

How it works

In stroke recovery, MSCs are studied for their potential to limit further tissue damage, calm post-stroke inflammation, support new blood vessel formation (angiogenesis), and encourage surrounding neurons to reorganize and compensate for damaged circuits — rather than for regenerating the specific neurons that were lost. This is an important distinction: current evidence supports a supportive, modulatory role, not direct neuron replacement.

Who may be considered

Patients with confirmed ischemic or hemorrhagic stroke who continue to experience motor, speech, cognitive, or coordination deficits after completing standard acute care and rehabilitation may be evaluated. Candidacy depends on:

• Time elapsed since the stroke (both very early and later chronic-phase presentations are studied, though evidence differs by timing — see Causes)
• Lesion location and size, confirmed via current imaging
• Overall health and ability to tolerate the chosen delivery method
• Realistic goals discussed and agreed upon with your specialist before treatment

Procedure at Viezec

1. Neuroimaging and stroke subtype confirmation using current scans.
2. Cell selection and preparation under GMP-certified lab conditions.
3. Delivery route selection — IV, intra-arterial, or stereotactic intracerebral, chosen per lesion characteristics (full detail under Delivery Methods).
4. Coordinated rehabilitation — physiotherapy, speech therapy, and occupational therapy scheduled alongside treatment, not after it.
5. Structured follow-up with functional outcome tracking at defined intervals.

What to expect

Reported improvements in motor function, speech, and daily-activity independence are generally assessed over a 3–9 month window, though timeframes and outcomes vary. Results depend heavily on stroke severity, timing, and how consistently rehabilitation is followed — this therapy is adjunctive to, not a replacement for, stroke-unit care and ongoing rehab.

Stem Cell Delivery Methods — Stroke

The delivery route matters because it determines how directly cells reach the affected brain region, balanced against procedural invasiveness and safety. Three approaches are used in current research:

• Intravenous (IV) infusion — the least invasive route; cells circulate systemically and are thought to exert effects partly through immune modulation rather than direct local delivery. Most commonly used in earlier-phase and larger trials due to its safety profile.
• Intra-arterial infusion — delivered via catheter into an artery supplying the affected brain region, allowing more targeted delivery than IV while remaining less invasive than direct brain injection.
• Intracerebral (stereotactic) injection — cells injected directly into or near the affected brain tissue under image guidance; more invasive, typically reserved for specific chronic-phase cases where targeted delivery is prioritized.

The choice depends on lesion location, whether the case is acute or chronic phase, and individual patient suitability — determined jointly by the treating neurologist and regenerative medicine specialist, not by patient preference alone. All routes are performed with imaging guidance and peri-procedural monitoring, and cell handling follows GMP and ISO-aligned practices.

For the underlying science on how these delivery choices affect outcomes across conditions, see Stem Cell Delivery Methods and Crossing the Blood-Brain Barrier.

Improvements & Results

Improvement after stroke is typically tracked across three domains, monitored separately because they don’t always improve at the same pace:

Motor recovery

Structured physiotherapy and task-specific training aim to improve limb strength, coordination, and walking ability. This is generally the most rehabilitation-dependent domain — consistency of therapy affects outcome as much as the treatment itself.

Speech & swallowing

Speech-language therapy supports regaining communication ability and safe swallowing, which reduces aspiration risk and related complications.

Functional independence

Occupational therapy and home adaptations support safer daily living and a faster return to routine activities.

How improvement is monitored, not just reported

Mechanism of Action: How Stem Cells Support Brain Recovery After Stroke

Current research frames MSCs as biological modulators rather than replacement cells — they don’t appear to regenerate the specific neurons lost during a stroke. Instead, they’re studied for four supportive mechanisms:

• Reduced inflammation — calming the inflammatory cascade that follows stroke and can worsen secondary tissue damage.
• Improved vascular environment — supporting healthier blood vessel function around the damaged area (angiogenesis).
• Neuronal support via growth factors — trophic signals that may help surviving neurons function and form new connections.
• Oxidative stress reduction — antioxidant effects that may help protect surrounding tissue from further damage.

This mechanism explains why current evidence points toward functional improvement (motor, speech, coordination gains) rather than structural reversal of the original brain injury — an important distinction when setting expectations before treatment.

Related reading: How Stem Cell Therapy Works, Stem Cell Healing Potential.

Our Promise

Viezec’s stroke recovery program is built around transparent, evidence-based regenerative care — not overstated claims. In practice:

• No cure claims. Stem cell therapy is offered as an investigational, supportive option — never marketed as a guaranteed cure for stroke-related deficits.
• Rehabilitation is never optional. Every treatment plan is paired with physiotherapy, speech therapy, or occupational therapy as clinically indicated — not offered as a standalone substitute for rehab.
• Named, credentialed medical oversight. Treatment plans are reviewed by qualified neurologists and regenerative medicine specialists.
• Regulatory transparency. Our protocols operate within India’s applicable regulatory framework for investigational stem cell use, and we disclose which framework applies to your specific case in writing.
• GMP-certified facilities. Cell handling is performed in GMP-certified laboratories with NABH/NABL accreditation.
• Written, itemized cost estimates. Provided after case evaluation, not before — because cost genuinely depends on stroke severity and protocol.
• Honest evidence communication. Where evidence is still evolving — as it is here — we say so directly and cite the specific trials our approach draws on (see Scientific References) rather than implying stronger proof than currently exists.

Treatment Results

Patients undergoing stem cell therapy for stroke at Viezec are followed using motor scales, speech and language evaluations, and imaging studies — not self-reported improvement alone — to track recovery. Commonly reported changes include improved limb strength, speech clarity in some cases, reduced spasticity, and greater independence in daily activities, generally assessed over 6–12 months.

Individual recovery depends heavily on stroke type, lesion location, and time elapsed since the event — the same variables discussed under Causes and Diagnosis. Stem cell therapy for stroke remains under active study; it is not a guaranteed cure, and results differ meaningfully between patients with similar diagnoses.

Discuss Your Case →

Testimonials

Sunil P. – Delhi, India – January 2020 – ⭐⭐⭐⭐☆
“After my stroke, my right side was weak. Viezec’s stem cell therapy helped me regain strength, and I can now manage daily tasks more easily.”

Mary L. – Chicago, USA – July 2020 – ⭐⭐⭐⭐⭐
“I struggled with speech and mobility post-stroke. Thanks to Viezec, my clarity of speech improved, and I can walk short distances again.”

Ahmed S. – Dubai, UAE – February 2021 – ⭐⭐⭐⭐☆
“My left arm was paralyzed after the stroke. Post treatment, movement slowly returned, and I feel much more independent now.”

Sofia T. – Madrid, Spain – October 2021 – ⭐⭐⭐⭐⭐
“Stem cell therapy at Viezec improved my coordination. My family noticed real progress in my balance and confidence.”

Omar K. – Cairo, Egypt – March 2022 – ⭐⭐⭐⭐☆
“I regained better control over my hands after treatment. Viezec’s doctors gave me guidance and constant support throughout the process.”

Emma W. – London, UK – August 2022 – ⭐⭐⭐⭐⭐
“Before therapy, speaking clearly was difficult. After Viezec’s care, my speech improved, and I feel confident communicating again.”

George R. – Toronto, Canada – April 2023 – ⭐⭐⭐⭐☆
“My stroke left me dependent on others. Stem cell therapy at Viezec gave me partial independence back, and my mobility improved.”

Fatima A. – Riyadh, Saudi Arabia – September 2023 – ⭐⭐⭐⭐⭐
“Post-stroke weakness made daily life tough. Viezec’s treatment brought back strength in my legs, and I’m more active again.”

Chloe D. – Sydney, Australia – January 2024 – ⭐⭐⭐⭐☆
“My coordination and balance improved after stem cell therapy. The compassionate care at Viezec gave me hope for full recovery.”

Marco B. – Rome, Italy – May 2025 – ⭐⭐⭐⭐⭐
“I had lost hope of walking after my stroke. Viezec’s therapy gave me visible improvements, and I can now walk with minimal support.”

Ahead of undergoing this process; a patient needs to understands that stem cell therapy is an experimental therapy that might not work at certain times. At the time of procedure, a patient might be refused the treatment or the proposed protocol might change depending on the patient’s health condition.

At Viezec Stem Cell Institute, our main motive is to give the best technology and safety available; of which has been proven across the globe.

As with any medical treatment, there are no guarantees or claims of cures are made as to the extent of the response to treatment. Every patient has different internal status of body; hence results vary from patient to patient, even with a similar diagnosis. This means that we cannot offer, infer or suggest that there is any certainty of a given outcome. For our any treatment we do not use embryonic or fetal cells.